Raymond James Financial Services Advisors’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-943
Closed -$23.9K 3474
2023
Q3
$23.9K Hold
943
﹤0.01% 3184
2023
Q2
$131K Buy
943
+89
+10% +$11.4K ﹤0.01% 3021
2023
Q1
$77.7K Buy
854
+81
+10% +$11K ﹤0.01% 3083
2022
Q4
$106K Sell
773
-1,503
-66% -$509K ﹤0.01% 3003
2022
Q3
$1.97M Sell
2,276
-5
-0.2% -$3.13K ﹤0.01% 1429
2022
Q2
$999K Buy
2,281
+590
+35% +$308K ﹤0.01% 1827
2022
Q1
$1.07M Buy
1,691
+265
+19% +$167K ﹤0.01% 1900
2021
Q4
$1.27M Buy
1,426
+702
+97% +$738K ﹤0.01% 1826
2021
Q3
$919K Buy
724
+145
+25% +$176K ﹤0.01% 2017
2021
Q2
$701K Sell
579
-23
-4% -$31K ﹤0.01% 2167
2021
Q1
$797K Sell
602
-30
-5% -$42.5K ﹤0.01% 1995
2020
Q4
$846K Buy
+632
New +$723K ﹤0.01% 1798

Other funds holding CANO

Raymond James Financial Services Advisors's CANO Position: Q4 2023 in Review

Raymond James Financial Services Advisors sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 943 shares — an estimated $23.9K sold.

Raymond James Financial Services Advisors first reported a position in CANO in Q4 2020 and held it in 12 quarters. The position peaked at $1.97M in Q3 2022. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Raymond James Financial Services Advisors reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 943 Cano Health, Inc. shares in Q4 2023, an estimated $23.9K.
  • Raymond James Financial Services Advisors first reported a position in Cano Health, Inc. in Q4 2020 and held it in 12 quarters.
  • Raymond James Financial Services Advisors's Cano Health, Inc. position peaked at $1.97M in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.